The evaluation of older patients with cervical cancer

Clinical Interventions in Aging

Volumn 8, Issue , 2013, Pages 783-788

  Gao, Ying ^a   Ma, Jin Lu ^a   Gao, Fei ^b   Song, Li Ping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cervical cancer; Older women

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGE; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; LYMPH NODE METASTASIS; MEDICAL RECORD; NEUTROPENIA; PELVIS LYMPH NODE; RETROSPECTIVE STUDY; SIDE EFFECT; SUBCUTANEOUS TISSUE; THROMBOCYTOPENIA; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER; WART VIRUS;

CERVICAL CANCER; OLDER WOMEN;

ADULT; AGE FACTORS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84879585226     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S45613     Document Type: Article

References (35)

1. Waggoner SE. Cervical cancer. Lancet. 2003;361(9376):2217-2225.
2. US National Institutes of Health. Cancer of the cervix uteri. 2005. Available from: http://www.cancer.gov. Accessed March 20, 2013.
3. Fox KV, Shah CA, Swisher EM, etal. An evaluation of cervical cancer in women age sixty and over. Gynecol Oncol. 2008;109(1):53-58.
4. Spanos WJ Jr, King A, Keeney E, Wagner R, Slater JM. Age as a prognostic factor in carcinoma of the cervix. Gynecol Oncol. 1989;35(1): 66-68.
5. Huang HJ, Chang TC, Hong JH, etal. Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (./=4 cm) stage IB and IIA cervical carcinoma. Int J Gynecol Cancer. 2003;13(2):204-211.
6. Wright JD, Gibb RK, Geevarghese S, etal. Cervical carcinoma in the elderly. An analysis of patterns of care and outcome. Cancer. 2005; 103(1):85-91.
7. Chen RJ, Lin YH, Chen CA, Huang SC, Chow SN, Hsieh CY. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol Oncol. 1999;73(2):184-190.
8. Junor EJ, Symonds RP, Watson ER, Lamont DW. Survival of younger cervical carcinoma patients treated by radical radiotherapy in the west of Scotland 1964-1984. Br J Obstet Gynaecol. 1989;96(5):522-528.
9. van der Graaf Y, Peer PG, Zielhuis GA, Vooijs PG. Cervical cancer survival in Nijmegen region, the Netherlands, 1970-1985. Gynecol Oncol. 1988;30(1):51-56.
10. Wimberger P, Lehmann N, Kimmig R, etal. Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol. 2006;100(2):300-307.
11. A Ioka, H Tsukuma, W Ajiki, et al. Influence of age on cervical cancer survival in Japan. Jpn J Clin Oncol. 2005;35(8):464-469.
12. Kasuya G, Ogawa K, Iraha S, etal. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival. Anticancer Res. 2013;33(5):2199-2204.
13. Razak NA, Mn K, Zubairi YZ, Naing NN, Zaki NM. Estimating the five-year survival of cervical cancer patients treated in Hospital Universiti Sains Malaysia. Asian Pac J Cancer Prev. 2013;14(2):825-828.
14. National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). Bethesda (MD): National Cancer Institute; 2006. Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf. Accessed May 31, 2013.
15. Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ. Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer. 2005;113(6):1005-1009.
16. Kastritis E, Bamias A, Bozas G, etal. The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy. Gynecol Oncol. 2007;104(2):372-376.
17. Brun JL, Stoven-Camou D, Trouette R, Lopez M, Chene G, Hocké C. Survival and prognosis of women with invasive cervical cancer according to age. Gynecol Oncol. 2003;91(2):395-401
18. Coker AL, Du XL, Fang S, Eggleston KS. Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts. Gynecol Oncol. 2006;102(2):278-284.
19. Lindegaard JC, Thranov IR, Engelholm SA. Radiotherapy in the management of cervical cancer in elderly patients. Radiother Oncol. 2000;56(1):9-15.
20. Goff BA, Muntz HG, Paley PJ, Tamimi HK, Koh WJ, Greer BE. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol. 1999;74(3):436-442.
21. Takeda N, Sakuragi N, Takeda M, etal. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand. 2002;81(12):1144-1151.
22. Hertel H, Köhler C, Elhawary T, Michels W, Possover M, Schneider A. Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer. Gynecol Oncol. 2002;87(1):46-51.
23. Marnitz S, Köhler C, Roth C, Füller J, Hinkelbein W, Schneider A. Is there a benefit of a pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol. 2005;99(3):536-544.
24. Sakuragi N, Satoh C, Takeda N, etal. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stage IB, IIA, IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999;85(7):1547-1554.
25. PE Castle, J Jeronimo, M Schiffman, et al. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res. 2006;66(2):1218-1224.
26. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338(7):423-428.
27. Walboomers JM, Jacobs MV, Manos MM, etal. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-19.
28. Gillison ML, Shah KV. Chapter9: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr. 2003;(31): 57-65.
29. Chuang LC, Chen HC, You SL, etal. Association between human papillomavirus and adenocarcinoma of rectum and recto-sigmoid junction: a cohort study of 10,612 women in Taiwan. Cancer Causes Control. 2010;21(12):2123-2128.
30. D'Souza G, Kreimer AR, Viscidi R, etal. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356(19):1944-1956.
31. Goto A, Li CP, Ota S, etal. Human papillomavirus infection in lung and esophageal cancers: analysis of 485Asian cases. J Med Virol. 2011; 83(8):1383-1390.
32. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol. 2009;113(4):917-924.
33. Goodheart M, Jacobson G, Smith BJ, Zhou L. Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity. Int J Gynecol Cancer. 2008;18(1):95-103.
34. van der Aa MA, Siesling S, Poll-Franse LV, Schutter EM, Lybeert ML, Coebergh JW. Age-specific differences in the treatment of cervical cancer in the east and the south of the Netherlands 1989-2004. Eur J Obstet Gynecol Reprod Biol. 2009;147(1):78-82.
35. Rose JH, O'Toole EE, Einstadter D. Patient age, well-being, perspectives, and care practices in the early treatment phase for late-stage cancer. J Gerontol A Biol Sci Med Sci. 2008;63(9):960-968.